DaVita Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
146 / 302
Position in country
5084 / 14179
Return on Assets, %
5.6
0.1
Net income margin, %
7.3
0.6
EBITDA margin, %
21.5
8.9
Debt to Equity, %
794.5
34.4
Intangible assets and goodwill, %
43.3
15.8
Revenue CAGR 3Y, %
1.6
11.7
Total Equity change 1Y, %
48.2
0
Revenue Y, % chg
4.5
1.8
P/E
17.6
25.7
P/BV
10.9
1.2
P/S
0.9
1.2
EV/S
1.7
1.5
EV/EBITDA
8.4
6.9
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
3.5
45.6
Forward P/E
14
17.8
Expected dividend per share
0
0
Payout Ratio, %
0
18.7
Competitors
Ranks
-
CorVel Corp
00%
-
Signify Health Inc
00%
-
Cigna Group
00%
-
CVS Health Corp
00%
-
Option Care Health Inc
00%
-
Oak Street Health Inc
00%
-
DaVita Inc
00%
-
Chemed Corp
00%
-
Quest Diagnostics Inc
00%
-
Laboratory Corporation of America Holdings
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Providers & Services
Sub-sector
Health Care
Capitalization (millions of $)
11437.8
Ticker
DVA.N
ISIN
US23918K1088
IPO date
1995-10-31
Availability on Russian exchanges
Yes
Reporting for
2024-02-14
Date fact. publication of reports
2023-12-31
Company Description
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: